Cart
sales@molnova.com
Trierucin
CAS No. 2752-99-0
Trierucin( —— )
Catalog No. M21429 CAS No. 2752-99-0
Trierucin is a trierucic acid triglyceride from the seed oil.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 35 | Get Quote |
|
| 25MG | 72 | Get Quote |
|
| 50MG | 125 | Get Quote |
|
| 100MG | 214 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTrierucin
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrierucin is a trierucic acid triglyceride from the seed oil.
-
DescriptionTrierucin is a trierucic acid triglyceride from the seed oil.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2752-99-0
-
Formula Weight1053.75
-
Molecular FormulaC69H128O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:32.5 mg/mL (3.84 mM)
-
SMILESCCCCCCCC/C=C\CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCC/C=C\CCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mersel M et al. Intracellular lipase activities in heart and skeletal muscle homogenates. The absence of trierucin cleavage by the heart: a possible biochemical basis for erucic acid lipidosis. Biochim Biophys Acta. 1979 Feb 26;572(2):218-24.
molnova catalog
related products
-
Lyticase
Lyticase, produced by a submerged culture of Arthrobacter luteus, is an enzyme preparation which effectively lyses cell walls of viable yeast cells. An essential enzyme responsible for lysis of viable yeast cells in this preparation is b-1, 3-glucan laminaripentaohydrolase.
-
Muscimol HBr
Muscimol HBr is an agonist of GABAA receptor.
-
TRi-1
TRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
